MedPath

Vistapharm Inc

🇺🇸United States
Ownership
-
Employees
-
Market Cap
-
Website

Clinical Trials

1

Active:0
Completed:1

Trial Phases

1 Phases

Phase 4:1

Drug Approvals

12

FDA:12

Drug Approvals

THYQUIDITY

Approval Date
Sep 14, 2022
FDA

Potassium Chloride

Approval Date
Aug 10, 2022
FDA

Nystatin

Approval Date
Jun 30, 2022
FDA

Phenytoin

Approval Date
Mar 14, 2022
FDA

Acyclovir

Approval Date
Feb 11, 2022
FDA

Oxycodone Hydrochloride

Approval Date
Feb 4, 2022
FDA

Megestrol Acetate

Approval Date
Dec 2, 2021
FDA

Methadone Hydrochloride

Approval Date
Nov 12, 2021
FDA

Methadone Hydrochloride

Approval Date
Sep 16, 2021
FDA

Oxycodone Hydrochloride

Approval Date
Aug 19, 2021
FDA
  • Prev
  • 1
  • 2
  • Next

Clinical Trials

Distribution across different clinical trial phases (1 trials with phase data)• Click on a phase to view related trials

Phase 4
1 (100.0%)

Evaluate The Pharmacokinetics and Safety Of Oxycodone Oral Solution In Pediatric and Adolescent Subjects

Phase 4
Completed
Conditions
Pain
Interventions
First Posted Date
2013-10-09
Last Posted Date
2023-01-11
Lead Sponsor
VistaPharm, Inc.
Target Recruit Count
97
Registration Number
NCT01959204
Locations
🇺🇸

CHOC Children's Hospital, Orange, California, United States

🇺🇸

Miami Children's Hospital, Miami, Florida, United States

🇺🇸

Tampa General Hospital, Tampa, Florida, United States

and more 6 locations

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.